Clinical Trials on Melanocytic Nevi in France

Total 352 results

University Hospital, Montpellier

Completed

Congenital Naevi of Lower Limb in the Child (NAEVUS)

Congenital Melanocytar Nevi in the Lower Limb

France
Centre Hospitalier Universitaire de Nice

Completed

Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face (PICAMEL)

Lentigo Maligna

France
Centre Hospitalier Universitaire de Saint Etienne

Completed

Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors (Micro3)

Melanoma | Nevus | Lentigo | Basal Cell Carcinoma | Seborrheic Keratosis | Lentigo Maligna

France
Nantes University Hospital
MEDA Pharma GmbH & Co. KG

Completed

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face (ImiReduc)

Lentigo Maligna Melanoma (Head or Neck)

France
Assistance Publique - Hôpitaux de Paris

Completed

Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients (IMMUMELA)

Melanoma

France
Nantes University Hospital
Bristol-Myers Squibb

Recruiting

Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients (Nivo-TIL)

Melanoma

France
Centre Antoine Lacassagne

Terminated

Study Assessing Two Models of Hypofractionated Protontherapy on Large Choroidal Melanomas (HYGROMEL)

Melanoma

France
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Tracing Dissemination of Melanoma Cells in Healthy Tissues (DISSEMELA)

Melanoma

France
Centre Hospitalier Universitaire de Besancon

Unknown

Study of Anti-telomerase T CD4 Immunity in Melanoma (LyTéloMel)

Melanoma

France
University Hospital, Grenoble
Etablissement Français du Sang

Recruiting

Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients (PHENOMENAL)

Melanoma

France
University Hospital, Strasbourg, France

Not yet recruiting

PRAME Immunohistochemistry as an Adjunct for Evaluating Ambiguous Melanocytic Proliferation (ANTIPRAME)

Melanoma

France
Institut Claudius Regaud

Completed

TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma (TICIMEL)

Melanoma

France
Centre Hospitalier Universitaire de Besancon
Centre Georges Francois Leclerc

Active, not recruiting

Analysis of Circulating Exosomes in Melanoma Patients (EXOMEL1)

Melanoma

France
Bristol-Myers Squibb

Active, not recruiting

A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France (AdjuMel)

Melanoma

France
Hospices Civils de Lyon

Recruiting

Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients (COLEMAN)

Melanoma

France
Institut Claudius Regaud

Recruiting

Prospective Melanoma Database

Melanoma

France
CHU de Reims

Completed

Clinical and Histological Features of Head and Neck Melanoma (head neck-mel)

Melanoma

France
CHU de Reims

Completed

Molecular Characterization of Advanced Stage Melanoma by Blood Sampling (MELCIRC)

Metastatic Melanoma

France
Nantes University Hospital
UMR892

Completed

Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study (MelSort)

Metastatic Melanoma

France
CHU de Reims

Unknown

Molecular Characterization of Primary Mucosal Melanoma (MELMUQ)

Mucosal Melanoma

France
University Hospital, Caen

Completed

Study Multicentre Evaluating the Effectiveness and Toxicity Sorafenib (Nexavar®) in Adult Patients With Uveal Melanoma and Metastatic Dissemination (O-Mel-Sora)

Uveal Melanoma

France
Assistance Publique Hopitaux De Marseille

Unknown

Study of Risk Factors and Clinical Characterization of Rapidly Growing Melanoma

Melanoma Cancer

France
Institut Curie

Unknown

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Intraocular Melanoma

France
University Hospital, Montpellier
Saint-Louis Hospital, Paris, France

Completed

Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old (TOLBRIPA)

Metastatic Melanoma

France
Hospices Civils de Lyon

Recruiting

Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma (MELANOPREDICT)

Melanoma

France
Institut Claudius Regaud

Active, not recruiting

Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients (IMMUSPHINX)

Melanoma

France
Hospices Civils de Lyon

Recruiting

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma (Mel-ImmAdj)

Melanoma

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Immune Profiles Evolution Under Immunotherapy for Melanoma (EPITHEM)

Melanoma

France
Rennes University Hospital
QIAGEN Gaithersburg, Inc

Completed

cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project (KitMel)

Melanoma

France
Institut Claudius Regaud

Completed

Optimization of the Patient Care Pathway in Immuno-oncology (OPTIMMUNO)

Melanoma

France
Institut Curie

Completed

Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU) (ctDNA MU)

Choroidal Melanoma

France
Centre Hospitalier Universitaire de Nice

Completed

Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes (EXOSOMES)

Metastatic Melanoma

France
Assistance Publique Hopitaux De Marseille

Completed

Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study

Metastatic Melanoma

France
Centre Jean Perrin

Recruiting

Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012 (MELRIV-1)

Melanoma

France
Institut Curie

Completed

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

Choroidal Melanoma, Diffuse

France
Assistance Publique - Hôpitaux de Paris

Completed

Multicentric Cohort of Melanoma Patients in Ile de France Area (Melan-Cohort)

Melanoma | Genetic Polymorphism

France
Centre Hospitalier Universitaire de Nice

Completed

Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy (AMMAM)

Metastatic (Stage IV) Melanoma

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma (PICASSO)

Melanoma

France
Institut Claudius Regaud

Completed

TNF in Melanoma Patients Treated With Immunotherapy (MELANFα)

Melanoma

France
Hospices Civils de Lyon

Completed

Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma (IMMUNONIVO)

Metastatic Melanoma

France
Hospices Civils de Lyon

Completed

Pre Transplantation Melanoma (MPG)

Malignant Melanoma

France
Centre Hospitalier Universitaire, Amiens

Unknown

New Tumor Models in Three Dimensions and in a Human Skin Environment for Personalized Melanoma Therapy (SkinTher)

Melanoma (Skin)

France
Bristol-Myers Squibb

Completed

Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma

Melanoma

France
Hospices Civils de Lyon

Unknown

Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies (PAIR)

Metastatic Melanoma

France
Nantes University Hospital

Completed

Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist (OASE Melanome)

Patients at Risk for Melanoma

France
Nantes University Hospital

Completed

COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

Patients at Risk for Melanoma

France
Hospices Civils de Lyon

Completed

Association of Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic Melanoma : a Retrospective Case-control Study. (CHLORO-DATRAM)

Dermatology and Oncology

France
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Completed

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma (GeniusVac-Mel4)

Melanoma | Effects of Immunotherapy | Tumor Vaccines

France
University Hospital, Strasbourg, France
Bristol-Myers Squibb

Completed

Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis (CRIRIN)

Melanoma (Skin)

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

France

3

Subscribe